Literature DB >> 26955893

Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review.

Christopher A Tan1, Marina Rabideau1, Amy Blevins2, Marjorie Jody Westbrook1, Tali Ekstein1, Keith Nykamp1, Anne Deucher1,3, Amy Harper2, Laurie Demmer2.   

Abstract

Pathogenic variants in the mitofusin 2 gene (MFN2) are the most common cause of autosomal dominant Charcot-Marie-Tooth (CMT2) disease, which is typically characterized by axonal sensorimotor neuropathy. We report on a 7-month-old white female with hypotonia, motor delay, distal weakness, and motor/sensory axonal neuropathy in which next-generation sequencing analysis identified compound heterozygous pathogenic variants (c.2054_2069_1170del and c.392A>G) in MFN2. A review of the literature reveals that sporadic and familial cases of compound heterozygous or homozygous pathogenic MFN2 variants have been infrequently described, which indicates that MFN2 can also be inherited in a recessive manner. This case highlights several clinical findings not typically associated with MFN2 pathogenic variants, including young age of onset and rapidly progressing diaphragmatic paresis that necessitated tracheostomy and mechanical ventilation, and adds to the growing list of features identified in autosomal recessive MFN2-related CMT2. Our patient with MFN2-related CMT2 expands the clinical and mutational spectrum of individuals with autosomal recessive CMT2 and identifies a new clinical feature that warrants further observation.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CMT2; Charcot-Marie-Tooth disease; mitofusin 2

Mesh:

Substances:

Year:  2016        PMID: 26955893     DOI: 10.1002/ajmg.a.37611

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Role of the Ca2+-Calcineurin-Nuclear Factor of Activated T cell Pathway in Mitofusin-2-Mediated Immune Function of Jurkat Cells.

Authors:  Xiu-Ping Xu; Yong-Ming Yao; Guang-Ju Zhao; Zong-Sheng Wu; Jun-Cong Li; Yun-Long Jiang; Zhong-Qiu Lu; Guang-Liang Hong
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

2.  CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity.

Authors:  Silvana Guerriero; Francesco D'Oria; Giacomo Rossetti; Rosa Anna Favale; Stefano Zoccolella; Giovanni Alessio; Vittoria Petruzzella
Journal:  Int Med Case Rep J       Date:  2020-02-20

Review 3.  Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.

Authors:  Michela Di Nottia; Daniela Verrigni; Alessandra Torraco; Teresa Rizza; Enrico Bertini; Rosalba Carrozzo
Journal:  Genes (Basel)       Date:  2021-02-10       Impact factor: 4.096

4.  Multiple respiratory complications in a patient with Charcot-Marie-Tooth disease with MFN2 mutation.

Authors:  Tomoya Sano; Jun Miyata; Akira Matsukida; Chie Watanabe; Ryohei Suematsu; Yoichi Tagami; Yoshifumi Kimizuka; Yuji Fujikura; Akihiko Kawana
Journal:  Respir Med Case Rep       Date:  2022-02-17

5.  An MFN2-related Charcot-Marie-Tooth Disease Patient with Optic Nerve Atrophy, Neurogenic Bladder Dysfunction, and Diaphragmatic Weakness.

Authors:  Yasuyoshi Kimura; Akira Nishikawa; Akihiro Hashiguchi; Masaki Etoh; Akiko Yoshimura; Kanako Asai; Noriko Miyashita; Hiroshi Takashima; Hisae Sumi; Takashi Naka
Journal:  Intern Med       Date:  2021-11-20       Impact factor: 1.282

Review 6.  Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases.

Authors:  Gerald W Dorn; Xiawei Dang
Journal:  Cells       Date:  2022-03-19       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.